Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Rubovszky G, Tondini C, Ciruelos EM, Gomez HL, Bonnefoi HR, Burstein HJ, Chini C, Puglisi F, Spazzapan S, Bernardo A, Climent MA, Bellet M, Ruhstaller T, Bermejo B, Chia SKL, Martino S, Geyer CE, Goetz MP, Ingle JN, Stearns V, Davidson NE, Le Du F, Müller B, Coleman RE, Loibl S, Winer EP, Ruepp B, Loi S, Láng I, Coates AS, Gelber RD, Goldhirsch A, Regan MM, International Breast Cancer Study Group, SOFT and TEXT Investigators.

Open source

DOI
10.1016/j.annonc.2026.05.704
Published
2026-06-01
Container
Ann Oncol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2026.05.704,
  title = {Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.},
  author = {Francis PA and  Pagani O and  Fleming GF and  Walley BA and  Colleoni M and  Rubovszky G and  Tondini C and  Ciruelos EM and  Gomez HL and  Bonnefoi HR and  Burstein HJ and  Chini C and  Puglisi F and  Spazzapan S and  Bernardo A and  Climent MA and  Bellet M and  Ruhstaller T and  Bermejo B and  Chia SKL and  Martino S and  Geyer CE and  Goetz MP and  Ingle JN and  Stearns V and  Davidson NE and  Le Du F and  Müller B and  Coleman RE and  Loibl S and  Winer EP and  Ruepp B and  Loi S and  Láng I and  Coates AS and  Gelber RD and  Goldhirsch A and  Regan MM and  International Breast Cancer Study Group and  SOFT and TEXT Investigators.},
  year = {2026},
  journal = {Ann Oncol},
  doi = {10.1016/j.annonc.2026.05.704},
  url = {https://doi.org/10.1016/j.annonc.2026.05.704}
}

RIS

TY  - JOUR
TI  - Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
AU  - Francis PA
AU  -  Pagani O
AU  -  Fleming GF
AU  -  Walley BA
AU  -  Colleoni M
AU  -  Rubovszky G
AU  -  Tondini C
AU  -  Ciruelos EM
AU  -  Gomez HL
AU  -  Bonnefoi HR
AU  -  Burstein HJ
AU  -  Chini C
AU  -  Puglisi F
AU  -  Spazzapan S
AU  -  Bernardo A
AU  -  Climent MA
AU  -  Bellet M
AU  -  Ruhstaller T
AU  -  Bermejo B
AU  -  Chia SKL
AU  -  Martino S
AU  -  Geyer CE
AU  -  Goetz MP
AU  -  Ingle JN
AU  -  Stearns V
AU  -  Davidson NE
AU  -  Le Du F
AU  -  Müller B
AU  -  Coleman RE
AU  -  Loibl S
AU  -  Winer EP
AU  -  Ruepp B
AU  -  Loi S
AU  -  Láng I
AU  -  Coates AS
AU  -  Gelber RD
AU  -  Goldhirsch A
AU  -  Regan MM
AU  -  International Breast Cancer Study Group
AU  -  SOFT and TEXT Investigators.
PY  - 2026
JO  - Ann Oncol
DO  - 10.1016/j.annonc.2026.05.704
UR  - https://doi.org/10.1016/j.annonc.2026.05.704
ER  - 

APA

PA, F., O, P., GF, F., BA, W., M, C., G, R., C, T., EM, C., HL, G., HR, B., HJ, B., C, C., F, P., S, S., A, B., MA, C., M, B., T, R., B, B., SKL, C., S, M., CE, G., MP, G., JN, I., V, S., NE, D., F, L. D., B, M., RE, C., S, L., EP, W., B, R., S, L., I, L., AS, C., RD, G., A, G., MM, R., Group, I. B. C. S., & Investigators., S. A. T. (2026). Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.. Ann Oncol. https://doi.org/10.1016/j.annonc.2026.05.704

Source records